Anti-Bacterial Agents

"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Substances that inhibit the growth or reproduction of BACTERIA.

Descriptor ID	D000900
MeSH Number(s)	D27.505.954.122.085
Concept/Terms	Anti-Bacterial Agents Anti-Bacterial Agents Agents, Anti-Bacterial Anti Bacterial Agents Antibacterial Agents Agents, Antibacterial Anti-Bacterial Compounds Anti Bacterial Compounds Compounds, Anti-Bacterial Bacteriocidal Agents Bacteriocidal Agents Agents, Bacteriocidal Bacteriocides Anti-Mycobacterial Agents Anti-Mycobacterial Agents Agents, Anti-Mycobacterial Anti Mycobacterial Agents Antimycobacterial Agents Agents, Antimycobacterial Antibiotics Antibiotics Antibiotic

Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Anti-Bacterial Agents [D27.505.954.122.085]

Below are MeSH descriptors whose meaning is related to "Anti-Bacterial Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.

Bar chart showing 1305 publications over 30 distinct years, with a maximum of 77 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	6	10	16
1997	8	6	14
1998	0	8	8
1999	9	7	16
2000	13	6	19
2001	10	13	23
2002	22	13	35
2003	28	13	41
2004	14	12	26
2005	18	16	34
2006	25	7	32
2007	39	16	55
2008	30	19	49
2009	22	22	44
2010	29	23	52
2011	21	21	42
2012	22	20	42
2013	34	25	59
2014	39	19	58
2015	46	22	68
2016	43	27	70
2017	32	26	58
2018	47	30	77
2019	51	25	76
2020	31	45	76
2021	20	40	60
2022	7	42	49
2023	14	38	52
2024	29	15	44
2025	8	2	10

Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.

Webster JL, Eppes S, Lee BK, Harrington NS, Goldstein ND. Contrasting methods to operationalize antibiotic exposure in clinical research: a real-world application on health care-associated Clostridioides difficile infection. Am J Epidemiol. 2025 May 07; 194(5):1448-1459.

View in: PubMed
Gil LA, Asti L, Chen HF, Saito JM, Pattisapu P, Deans KJ, Minneci PC. Cost-Effectiveness of Nonoperative Management vs Upfront Laparoscopic Appendectomy for Pediatric Uncomplicated Appendicitis for 1 Year. J Am Coll Surg. 2025 Mar 01; 240(3):288-298.

View in: PubMed
Durrani AF, Chaudhary V, Garg SJ. Reducing rates of endophthalmitis from intravitreal injections - strategies and areas of controversy. Curr Opin Ophthalmol. 2025 May 01; 36(3):229-236.

View in: PubMed
Delaney LJ, Machado P, Liu JB, Evans R, Winslow A, Zhao N, Kepler CK, Narayanan R, Ezeonu T, Soni V, Kaushal G, Hilliard R, Schaer TP, Hickok NJ, Forsberg F. Ultrasound-triggered release of vancomycin from a novel spinal device: Antibiotic release and efficacy in vivo. Int J Pharm. 2025 Feb 25; 671:125276.

View in: PubMed
Kugelman DN, Leal J, Shah S, Wrenn R, Mackowiak A, Ryan SP, Jiranek WA, Seyler TM, Seidelman J. How Often Is Rifampin Therapy Initiated and Completed in Patients With Periprosthetic Joint Infections? Clin Orthop Relat Res. 2025 Jan 23; 483(7):1215-1221.

View in: PubMed
Holubyeva A, Khin K, Gao T, Adair S, Wasenda E, Dhariwal L, Caraballo R, Lozo S, Rutledge J, Botros C. Onabotulinum Toxin A-Led Urinary Tract Infections-Should we Safeguard? A Randomized Controlled Trial. Int Urogynecol J. 2025 Feb; 36(2):469-474.

View in: PubMed
DeRyke CA, Wise MG, Bauer KA, Siddiqui F, Young K, Motyl MR, Sahm DF. Antimicrobial Activity of Imipenem/Relebactam and Comparator Agents Against Gram-Negative Isolates Collected From Pediatric Patients: SMART 2018-2022 Global Surveillance. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).

View in: PubMed
Menon SV, Sandhwar V, Chaudhary S, Bhanot D, Arulselvan P, Govindasamy C, Khan MI, Suriyaprakash J, Thangavelu I, Boopathi TS. TiO2-sodium alginate core-shell nanosystem for higher antimicrobial wound healing application. Int J Biol Macromol. 2025 Apr; 300:139923.

View in: PubMed
Patwardhan UM, Kahan A, Eldredge RS, Russell KW, Lee J, Short SS, Padilla B, Cairo SB, Acker SN, Jensen AR, Kelley-Quon LI, Rothstein DH, Fialkowski EA, Chao SD, Gillory L, Pandya S, Diaz-Miron J, Ignacio RC. Comparison of Postoperative Antibiotic Protocols for Pediatric Complicated Appendicitis: A Western Pediatric Surgery Research Consortium Study. J Pediatr Surg. 2025 Apr; 60(4):162165.

View in: PubMed
Jones N, Shih MC, Healey E, Zhai CW, Advani S, Smith-McLallen A, Sontag D, Kanjilal S. Use of Machine Learning to Assess the Management of Uncomplicated Urinary Tract Infection. JAMA Netw Open. 2025 01 02; 8(1):e2456950.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement